Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by donkeyfeatherson Apr 23, 2021 1:29pm
284 Views
Post# 33055955

RE:You know this KOL event is probably pretty good

RE:You know this KOL event is probably pretty goodGood stuff to ponder...and,

I just have to say MM, that corruption blossoms in warm dark places where accountability takes a back seat to an argument around 1/10 ratios.  I appreciate that this company didn’t have the resources to staff out in the hundreds, but Dr. Phil is NOT so important as to be The binary that’s too big to fail: Where he either gets to take on more than (historically) he has a demonstrated competence in, or he’s out the door - on his own or through shareholder direction.  Plenty of people on this forum recognize that as company’s grow, you look at (review) the good & bad and figure out where changes are needed.  Dr. Phil realized he needed Dr.’s Witkowski and Wiseman, so he knows how to bring in experts.  Those on here saying “give him the boot” have discounted that fact to zero, and therefore we can discount their opinion accordingly.

But when does Dr. Phil get to confirm in himself “I’m above taking criticism from retail shareholders.”  Never.  Before the Can-of-worms BMWs pulled up and started flashing the inner lapels of their Hugo Boss outfits, we were the ones keeping this idea afloat.  And yes, the AGM is where we can say - “Hire someone who can pilot the sale of this outfit as well as you piloted the scientific team build.”  And that means get rid of the people hanging on because they introduced Frank to Phil.  That individual has been more that fairly compensated.  We, as retail shareholders, have not.  If the correcting of that imbalance makes some staff quit…they should have been shown the door long ago.  My sense is, they won’t leave just because people are asked to assume roles they are best suited (not just to Hugo Boss) for.

DF

<< Previous
Bullboard Posts
Next >>